myLaminin Perspectives

CROs have evolved into essential partners in clinical trials, offering scalability, expertise, and global reach amid rising complexity. However, fragmented systems, blurred oversight, and data silos create risk. The future lies in integrated platforms like myLaminin that connect sponsors, CROs, and sites, improving transparency, governance, and execution across decentralized research ecosystems.

Non-compliance in research is more than a policy risk, it’s a financial and reputational one. With rising regulatory demands across Canada, the U.S., and Europe, many teams underestimate the true cost of getting it wrong. This article explores the real-world impact of non-compliance, from lost funding to multi-million-dollar fines, and introduces a practical Cost of Non-Compliance Calculator to help assess your risk.